- Home
- CSBR
as 11-21-2024 4:00pm EST
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | BALTIMORE |
| Market Cap: | 65.9M | IPO Year: | 1986 |
| Target Price: | $6.00 | AVG Volume (30 days): | 11.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.25 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.60 - $7.13 | Next Earning Date: | 12-10-2024 |
| Revenue: | $51,655,000 | Revenue Growth: | -1.96% |
| Revenue Growth (this year): | 9.27% | Revenue Growth (next year): | 9.76% |
Latest Champions Oncology Inc. News
CSBR Breaking Stock News: Dive into CSBR Ticker-Specific Updates for Smart Investing
Simply Wall St.
18 days ago
Champions Oncology (NASDAQ:CSBR) shareholders have endured a 61% loss from investing in the stock three years ago
ACCESSWIRE
a month ago
Champions Oncology Announces Agreement with Weill Cornell Medicine
GuruFocus.com
a month ago
Champions Oncology Inc (CSBR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...
GuruFocus.com
a month ago
Champions Oncology Inc (CSBR) Q4 2024 Earnings Call Highlights: Navigating Challenges and ...
Simply Wall St.
2 months ago
Champions Oncology (NASDAQ:CSBR) Is In A Strong Position To Grow Its Business
ACCESSWIRE
2 months ago
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million
ACCESSWIRE
2 months ago
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024
Simply Wall St.
3 months ago
This Champions Oncology Insider Increased Their Holding By 14% Last Year
Compare CSBR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CSBR Champions Oncology Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.